Edition:
United States

DaVita Inc (DVA.N)

DVA.N on New York Stock Exchange

66.49USD
9 Dec 2016
Change (% chg)

$0.21 (+0.32%)
Prev Close
$66.28
Open
$66.31
Day's High
$66.65
Day's Low
$66.00
Volume
263,052
Avg. Vol
554,775
52-wk High
$78.77
52-wk Low
$54.50

DVA.N

Chart for DVA.N

About

DaVita Inc., formerly DaVita HealthCare Partners Inc., is a provider of kidney care services. The Company operates Kidney Care division and HealthCare Partners (HCP) division. The Company's segments include U.S. dialysis and related lab services, HCP and Other-Ancillary services and strategic initiatives. The Company's Kidney... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $13,083.67
Shares Outstanding(Mil.): 197.40
Dividend: --
Yield (%): --

Financials

  DVA.N Industry Sector
P/E (TTM): 19.17 37.99 30.35
EPS (TTM): 3.46 -- --
ROI: 5.77 8.81 15.27
ROE: 14.46 12.35 16.60

BRIEF-DaVita announces partnership with Rock Health

* Announces a partnership with Rock Health, first venture fund Source text for Eikon: Further company coverage:

Nov 29 2016

BRIEF-Healthcare Partners offers to acquire 30.99 pct of Abano Healthcare for NZ$10 per share

* offering to acquire 30.99% of fully paid ordinary shares in Abano Healthcare Group at offer price of nz$10 per share in cash Source text for Eikon: Further company coverage:

Nov 24 2016

BRIEF-Davita Inc says Q3 earnings per share $2.76 including items

* Total u.s. Dialysis treatments for q3 were 6,887,992, or 87,190 treatments per day, representing a per day increase of 4.2% over q3 of 2015

Nov 02 2016

BRIEF-DaVita announces change for medicaid patients seeking affordable care act plan coverage

* DaVita announces change for medicaid patients seeking affordable care act plan coverage

Oct 31 2016

BRIEF-Davita Healthcare posts Q2 adj. earnings per share $1.01

* Q2 earnings per share view $0.98 -- Thomson Reuters I/B/E/S

Aug 08 2016

Earnings vs. Estimates